International

The Trump Administration Wants Your Opinion on Cannabis

Last Wednesday, the Food and Drug Administration (FDA) announced it was seeking public comments regarding “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use ….” of cannabis and other substances currently under international review. If you want to take FDA up on its offer, go here. The …

The Trump Administration Wants Your Opinion on Cannabis Read More »

Canada Cannabis Legalization Today: U.S. Customs and Border Protection Update

U.S. border policy on Canadians and marijuana is tough.On the eve of the Canada’s cannabis legalization, the U.S. Customs and Border Protection (“CBP”) held a teleconference to explain the agency’s enforcement policy and field questions from journalists. The on-the-record teleconference featured the head of the CBP’s Office of Field Operations, which has a staff of …

Canada Cannabis Legalization Today: U.S. Customs and Border Protection Update Read More »

Bumps Ahead: The U.S. Border After Canada Cannabis Legalization

Canada’s cannabis legalization creates yet another wrinkle in the relations between the U.S. and its northern neighbor. U.S. Attorney General Jeffrey Sessions harbors a well known hatred towards anything cannabis and he clearly has no love for Canada’s Cannabis Act either. What will this mean though for Canadians who are 100% legally involved in Canada’s …

Bumps Ahead: The U.S. Border After Canada Cannabis Legalization Read More »

The FDA and DEA Disagree Over CBD Scheduling

FDA and DEA are in a bit of a tiff over CBD. Last week, following the highly-anticipated U.S. Food and Drug Administration (“FDA”) approval of Epidiolex, G.W. Pharma’s oral cannabidiol (“CBD”) solution for the treatment of seizure associated with Lennox-Gastraut and Dravet syndrome, the Drug Enforcement Administration (“DEA”) issued a Final Order rescheduling FDA-approved drugs …

The FDA and DEA Disagree Over CBD Scheduling Read More »